{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T04:45:13Z","timestamp":1770698713109,"version":"3.49.0"},"reference-count":22,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":4414,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1034\/j.1600-6143.2003.08062.x","type":"journal-article","created":{"date-parts":[[2003,8,15]],"date-time":"2003-08-15T15:33:12Z","timestamp":1060961592000},"page":"299-305","source":"Crossref","is-referenced-by-count":43,"title":["Mortality Benefit of Beta Blockade in Patients with Acute Coronary Syndromes Undergoing Coronary Intervention:"],"prefix":"10.1034","volume":"16","author":[{"given":"KEITH","family":"ELLIS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JAMES E.","family":"TCHENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHELLY","family":"SAPP","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ERIC J.","family":"TOPOL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"MICHAEL LINCOFF","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1034\/j.1600-6143.2003.08062.x-BIB1","first-page":"3","volume-title":"Manual of Cardiovascular Medicine","author":"Marso","year":"2000"},{"key":"10.1034\/j.1600-6143.2003.08062.x-BIB2","first-page":"395","volume-title":"Textbook of Cardiovascular Medicine","author":"Topol","year":"1998"},{"key":"10.1034\/j.1600-6143.2003.08062.x-BIB3","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0735-1097(94)00552-2","article-title":"Treatment with beta-adrenergic blocking agents after myocardial infarction: From randomized trials to clinical practice","volume":"25","author":"Miviskin","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1034\/j.1600-6143.2003.08062.x-BIB4","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","article-title":"Beta blockade after myocardial infarction: Systematic review and meta regression analysis","volume":"318","author":"Freemantle","year":"1999","journal-title":"Br Med J"},{"key":"10.1034\/j.1600-6143.2003.08062.x-BIB5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/oxfordjournals.eurheartj.a061845","article-title":"A randomized placebo controlled international trial","volume":"6","author":"Metoprolol in acute myocardial infarction (MIAMI)","year":"1985","journal-title":"Eur Heart J"},{"key":"10.1034\/j.1600-6143.2003.08062.x-BIB6","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL randomized intervention trial in congestive heart failure (MERIT-HF)","volume":"353","author":"MERIT-HF Study Group","year":"1999","journal-title":"Lancet"},{"key":"10.1034\/j.1600-6143.2003.08062.x-BIB7","first-page":"1765","article-title":"The cardiac insufficiency bisoprolol study","volume":"90","author":"CIBIS Investigators and Committees","year":"1994","journal-title":"Circulation"},{"key":"10.1034\/j.1600-6143.2003.08062.x-BIB8","doi-asserted-by":"crossref","first-page":"1A","DOI":"10.1016\/S0002-9149(99)00358-6","article-title":"Consensus recommendations for the management of chronic heart failure","volume":"83","author":"Packer","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1034\/j.1600-6143.2003.08062.x-BIB9","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0140-6736(78)91628-8","article-title":"Protective effect of propranolol in threatened myocardial infarction","volume":"2","author":"Norris","year":"1978","journal-title":"Lancet"},{"key":"10.1034\/j.1600-6143.2003.08062.x-BIB10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0033-0620(93)90018-9","article-title":"Early intravenous beta blocker combined with thrombolytic therapy for acute myocardial infarction: The thrombolysis in myocardial infarction (TIMI-2) Trial","volume":"36","author":"Borzak","year":"1993","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1034\/j.1600-6143.2003.08062.x-BIB11","first-page":"57","article-title":"Randomized trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1","volume":"2","author":"ISIS-1 Collaborative Group","year":"1986","journal-title":"Lancet"},{"key":"10.1034\/j.1600-6143.2003.08062.x-BIB12","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.1982.03320370021023","article-title":"A randomized trial of propranolol in patients with acute myocardial infarction","volume":"247","author":"Beta Blocker Heart Attack Trial Research Group (BHAT)","year":"1982","journal-title":"JAMA"},{"key":"10.1034\/j.1600-6143.2003.08062.x-BIB13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/01.CIR.102.2.166","article-title":"Cardioprotective effect of prior beta blocker therapy in reducing creatine kinase-MB elevation after coronary intervention","volume":"102","author":"Sharma","year":"2000","journal-title":"Circulation"},{"key":"10.1034\/j.1600-6143.2003.08062.x-BIB14","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199404073301402","article-title":"Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high risk coronary angioplasty","volume":"330","author":"The EPIC Investigators","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1034\/j.1600-6143.2003.08062.x-BIB15","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM199706123362401","article-title":"Effect of the platelet glycoprotein IIb\/IIIa receptor inhibitor abciximab with lower heparin dosages on ischemic complications of percutaneous coronary revascularization","volume":"336","author":"EPILOG Investigators","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1034\/j.1600-6143.2003.08062.x-BIB16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)06113-3","article-title":"Randomized, placebo controlled and balloon angioplasty controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb\/IIIa blockade","volume":"352","author":"The EPISTENT Investigators","year":"1998","journal-title":"Lancet"},{"key":"10.1034\/j.1600-6143.2003.08062.x-BIB17","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(96)10452-9","article-title":"Randomized placebo controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The capture study","volume":"349","author":"The CAPTURE Investigators","year":"1997","journal-title":"Lancet"},{"key":"10.1034\/j.1600-6143.2003.08062.x-BIB18","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/01.CIR.98.8.734","article-title":"Randomized, placebo controlled trial of platelet glycoprotein IIb\/IIIa blockade with primary angioplasty for acute myocardial infarction","volume":"98","author":"The RAPPORT Investigators","year":"1998","journal-title":"Circulation"},{"key":"10.1034\/j.1600-6143.2003.08062.x-BIB19","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/01.CIR.80.2.410","article-title":"Unstable angina, a classification","volume":"80","author":"Braunwald","year":"1989","journal-title":"Circulation"},{"key":"10.1034\/j.1600-6143.2003.08062.x-BIB20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: An overview of the randomized trials","volume":"27","author":"Yusuf","year":"1985","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1034\/j.1600-6143.2003.08062.x-BIB21","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/hrt.56.5.400","article-title":"Early treatment of unstable angina in the coronary care unit: A randomised, double blind, placebo controlled comparison of recurrent ischemia in patients treated with nifedipine or metoprolol or both","volume":"56","author":"Holland interuniversity nifedipine\/metoprolol trial (HINT) research group","year":"1986","journal-title":"Br Heart J"},{"key":"10.1034\/j.1600-6143.2003.08062.x-BIB22","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1001\/jama.1988.03410150107041","article-title":"Overview of results of randomized clinical trials","volume":"260","author":"Yusuf","year":"1988","journal-title":"JAMA"}],"container-title":["The Journal of Interventional Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-6143.2003.08062.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T18:04:32Z","timestamp":1626977072000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1034\/j.1600-6143.2003.08062.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,8]]}},"URL":"https:\/\/doi.org\/10.1034\/j.1600-6143.2003.08062.x","relation":{},"ISSN":["0896-4327","1540-8183"],"issn-type":[{"value":"0896-4327","type":"print"},{"value":"1540-8183","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}